JPS61112027A - 制癌剤 - Google Patents
制癌剤Info
- Publication number
- JPS61112027A JPS61112027A JP59233310A JP23331084A JPS61112027A JP S61112027 A JPS61112027 A JP S61112027A JP 59233310 A JP59233310 A JP 59233310A JP 23331084 A JP23331084 A JP 23331084A JP S61112027 A JPS61112027 A JP S61112027A
- Authority
- JP
- Japan
- Prior art keywords
- 3pts
- root
- juzen
- taiho
- rhizome
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000003327 cancerostatic effect Effects 0.000 title abstract 4
- 239000009569 juzentaihoto Substances 0.000 claims abstract description 10
- 239000002246 antineoplastic agent Substances 0.000 claims description 20
- 229940041181 antineoplastic drug Drugs 0.000 claims description 5
- 239000000284 extract Substances 0.000 abstract description 9
- 239000000843 powder Substances 0.000 abstract description 8
- 230000000694 effects Effects 0.000 abstract description 5
- 230000004083 survival effect Effects 0.000 abstract description 5
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract description 4
- 239000002775 capsule Substances 0.000 abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 4
- 201000010099 disease Diseases 0.000 abstract description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 3
- 235000008434 ginseng Nutrition 0.000 abstract description 3
- 206010003445 Ascites Diseases 0.000 abstract description 2
- 238000007796 conventional method Methods 0.000 abstract description 2
- 206010061428 decreased appetite Diseases 0.000 abstract description 2
- 239000007788 liquid Substances 0.000 abstract description 2
- 231100000053 low toxicity Toxicity 0.000 abstract description 2
- 240000004371 Panax ginseng Species 0.000 abstract 3
- 235000002789 Panax ginseng Nutrition 0.000 abstract 3
- 239000003795 chemical substances by application Substances 0.000 abstract 3
- 244000269722 Thea sinensis Species 0.000 abstract 2
- 241000544270 Angelica acutiloba Species 0.000 abstract 1
- 241001061264 Astragalus Species 0.000 abstract 1
- 241000132011 Atractylodes lancea Species 0.000 abstract 1
- 201000009030 Carcinoma Diseases 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 235000021511 Cinnamomum cassia Nutrition 0.000 abstract 1
- 241000533367 Cnidium officinale Species 0.000 abstract 1
- 241000233866 Fungi Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 244000236658 Paeonia lactiflora Species 0.000 abstract 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 abstract 1
- 241000405911 Rehmannia glutinosa Species 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 210000004233 talus Anatomy 0.000 abstract 1
- 230000001093 anti-cancer Effects 0.000 description 7
- 239000003814 drug Substances 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 241000411851 herbal medicine Species 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 241000202807 Glycyrrhiza Species 0.000 description 3
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 3
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 229940010454 licorice Drugs 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000002504 physiological saline solution Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 241000208340 Araliaceae Species 0.000 description 2
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 238000011047 acute toxicity test Methods 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 235000017803 cinnamon Nutrition 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 244000080208 Canella winterana Species 0.000 description 1
- 235000008499 Canella winterana Nutrition 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 235000000177 Indigofera tinctoria Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 229940017545 cinnamon bark Drugs 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229940097275 indigo Drugs 0.000 description 1
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP59233310A JPS61112027A (ja) | 1984-11-07 | 1984-11-07 | 制癌剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP59233310A JPS61112027A (ja) | 1984-11-07 | 1984-11-07 | 制癌剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS61112027A true JPS61112027A (ja) | 1986-05-30 |
| JPH0469618B2 JPH0469618B2 (enrdf_load_stackoverflow) | 1992-11-06 |
Family
ID=16953118
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP59233310A Granted JPS61112027A (ja) | 1984-11-07 | 1984-11-07 | 制癌剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS61112027A (enrdf_load_stackoverflow) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6071521A (en) * | 1989-09-04 | 2000-06-06 | Kim; Song Bae | Pharmaceutical composition having an antitumor activity and a process for preparation thereof |
| JP2004203855A (ja) * | 2002-06-24 | 2004-07-22 | Akira Awaya | アレルギー性鼻炎・結膜炎あるいは皮膚アレルギーやアトピー性皮膚炎の予防・治療法 |
-
1984
- 1984-11-07 JP JP59233310A patent/JPS61112027A/ja active Granted
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6071521A (en) * | 1989-09-04 | 2000-06-06 | Kim; Song Bae | Pharmaceutical composition having an antitumor activity and a process for preparation thereof |
| JP2004203855A (ja) * | 2002-06-24 | 2004-07-22 | Akira Awaya | アレルギー性鼻炎・結膜炎あるいは皮膚アレルギーやアトピー性皮膚炎の予防・治療法 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0469618B2 (enrdf_load_stackoverflow) | 1992-11-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS5936619A (ja) | 制癌補助剤 | |
| WO2009117953A1 (zh) | 一种具有抗抑郁、抗焦虑作用的药物组合物及其制备方法 | |
| CN100469377C (zh) | 一种治疗前列腺炎的软胶囊 | |
| CN108434399B (zh) | 一种乳腺癌化疗增敏的中药组合物及制备方法 | |
| JPH04243832A (ja) | 自己免疫疾患治療剤 | |
| CN101088542A (zh) | 一种治疗胸痹的中药复方制剂 | |
| US5055297A (en) | Immunopotentiator | |
| JPS61112027A (ja) | 制癌剤 | |
| JPS6025933A (ja) | 癌症状改善剤 | |
| JPS61115029A (ja) | 制癌剤 | |
| JPH01246224A (ja) | 抗痴呆症剤 | |
| CN101549140B (zh) | 治疗艾滋病的中药组合物及其制备方法 | |
| JPS61109733A (ja) | 制癌剤 | |
| JPH02300131A (ja) | 発癌抑制剤 | |
| JPH0469617B2 (enrdf_load_stackoverflow) | ||
| JPS6256435A (ja) | 冠血管拡張剤 | |
| CN110755601A (zh) | 一种治疗hiv/aids免疫重建缺陷的芸豆凝集素植物药组合物和制备方法及其应用 | |
| JPS61194031A (ja) | 制癌作用増強剤 | |
| CN106563076B (zh) | 一种治疗胃病的药物及其制作方法 | |
| JPH0643327B2 (ja) | 免疫賦活剤 | |
| CN104055963A (zh) | 一种减脂中药组合物及制备方法 | |
| JPH02255621A (ja) | 降圧剤 | |
| JPH0232025A (ja) | 制癌補助剤 | |
| JPH01153646A (ja) | 抗レトロウイルス剤 | |
| CN110051811B (zh) | 一种抗甲亢和护肝的中药复方制剂及其制备方法 |